Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
sunitinib teva 25 mg trde kapsule
sunitinib - kapsula, trda - sunitinib 25 mg / 1 kapsula - sunitinib
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
sunitinib teva 50 mg trde kapsule
sunitinib - kapsula, trda - sunitinib 50 mg / 1 kapsula - sunitinib
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
odomzo
sun pharmaceutical industries europe b.v. - sonidegib difosfat - karcinom, bazalna celica - antineoplastična sredstva - odomzo je indiciran za zdravljenje odraslih bolnikov z lokalno napredovalim karcinomom bazalnih celic (bcc), ki niso primerni za kurativno kirurgijo ali radioterapijo.
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastična sredstva - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
sunitinib pharmascience 12,5 mg trde kapsule
sunitinib - kapsula, trda - sunitinib 12,5 mg / 1 kapsula
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
sunitinib pharmascience 25 mg trde kapsule
sunitinib - kapsula, trda - sunitinib 25 mg / 1 kapsula
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
sunitinib pharmascience 50 mg trde kapsule
sunitinib - kapsula, trda - sunitinib 50 mg / 1 kapsula
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
lusmose 50 mg trde kapsule
sunitinib - kapsula, trda - sunitinib 50 mg / 1 kapsula - sunitinib
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastična sredstva - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
aloxi
helsinn birex pharmaceuticals ltd. - palonosetronijev hidroklorid - vomiting; cancer - antiemetics in antinauseants, serotonina (5ht3) antagonisti - aloxi je navedeno v odraslih za:preprečevanje akutne slabosti in bruhanja, povezanih z močno emetogenic rak, kemoterapija,preprečevanje slabosti in bruhanja, povezanih z zmerno emetogenic kemoterapijo raka. aloxi je navedeno v pediatričnih bolnikih od 1 meseca starosti in starejših za:preprečevanje akutne slabosti in bruhanja, povezanih z močno emetogenic rak, kemoterapija in preprečevanje slabosti in bruhanja, povezanih z zmerno emetogenic kemoterapijo raka.